Thermo Fisher Scientific Inc. (TMO) — Financial statements
Income statement, balance sheet, and cash flow for Thermo Fisher Scientific Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 44,556↑3.9% | 42,879↑0.1% | 42,857↓4.6% | 44,915↑14.5% | 39,211 | |
| Cost of Revenue | 27,778↑10.4% | 25,151↓2.0% | 25,663↓0.9% | 25,904↑32.3% | 19,577 | |
| Gross Profit | 16,778↓5.4% | 17,728↑3.1% | 17,194↓9.6% | 19,011↓3.2% | 19,634 | |
| Operating Expenses | ||||||
| R&D Expenses | 1,397↑0.5% | 1,390↑4.0% | 1,337↓9.1% | 1,471↑4.6% | 1,406 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 7,272↓16.2% | 8,676↑3.2% | 8,411↓6.7% | 9,015↑14.0% | 7,910 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 8,669↓13.9% | 10,066↑3.3% | 9,748↓7.0% | 10,486↑12.6% | 9,316 | |
| Total Costs & Expenses | 36,447↑3.5% | 35,217↓0.5% | 35,411↓2.7% | 36,390↑25.9% | 28,893 | |
| Operating Results | ||||||
| Operating Income | 8,109↑5.8% | 7,662↑2.9% | 7,446↓12.7% | 8,525↓17.4% | 10,318 | |
| Depreciation & Amortization | 2,780↓10.6% | 3,108↓8.7% | 3,406↑0.7% | 3,381↑30.4% | 2,592 | |
| EBITDA | 11,466↓2.8% | 11,800↑5.4% | 11,195↓6.3% | 11,942↓0.2% | 11,969 | |
| EBIT | 8,686↓0.1% | 8,692↑11.6% | 7,789↓9.0% | 8,561↓8.7% | 9,377 | |
| Interest & Other Income | ||||||
| Net Interest Income | -426↑26.0% | -576↑5.9% | -612↓34.8% | -454↑7.9% | -493 | |
| Interest Income | 993↓7.9% | 1,078↑22.6% | 879↑223.2% | 272↑532.6% | 43 | |
| Interest Expense | 1,419↓14.2% | 1,654↑10.9% | 1,491↑105.4% | 726↑35.4% | 536 | |
| Non-Operating Income | -577↑44.0% | -1,030↓200.3% | -343↓852.8% | -36↓103.8% | 941 | |
| Other Income / Expenses | -842↓26.2% | -667↑44.7% | -1,207↓40.0% | -862↑41.8% | -1,481 | |
| Income Before Tax | 7,267↑3.9% | 6,995↑12.1% | 6,239↓18.6% | 7,663↓13.3% | 8,837 | |
| Income Tax Expense | 547↓16.7% | 657↑131.3% | 284↓59.6% | 703↓36.6% | 1,109 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 6,720↑6.0% | 6,338↑6.4% | 5,955↓14.4% | 6,960↓9.9% | 7,728 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 6,737↑6.3% | 6,335↑5.7% | 5,995↓13.7% | 6,950↓10.0% | 7,725 | |
| Bottom-Line Net Income | 6,704↑5.8% | 6,335↑5.7% | 5,995↓13.7% | 6,950↓10.0% | 7,725 | |
| EPS (Basic) | 17.77↑7.2% | 16.58↑6.8% | 15.53↓12.4% | 17.73↓9.6% | 19.61 | |
| EPS (Diluted) | 17.74↑7.3% | 16.53↑7.0% | 15.45↓12.4% | 17.64↓9.4% | 19.46 | |
| Weighted Average Shares | 376↓1.6% | 382↓1.0% | 386↓1.5% | 392↓0.5% | 394 | |
| Weighted Average Diluted Shares | 377↓1.6% | 383↓1.3% | 388↓1.5% | 394↓0.8% | 397 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.